Clinical Trials Directory

Trials / Terminated

TerminatedNCT02479438

Gastroesophageal Reflux Disease Prospective Registry

Status
Terminated
Phase
Study type
Observational
Enrollment
744 (actual)
Sponsor
Baylor Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this registry is to evaluate information to determine which operations and treatments for gastroesophageal reflux disease or similar diseases of the stomach, esophagus or digestive tract are providing the most benefit including the long-term effects of treatment (or no treatment) and the progression of the disease over time.

Detailed description

All patients in this registry will have a diagnosis of gastroesophageal reflux disease or a similar disease of the stomach, esophagus or digestive tract. Each patient undergoing anti-reflux surgery will be asked to participate in the registry to gather preoperative, intraoperative and postoperative outcomes. The data collected from the registry will be used to assess the outcome of various treatments, both standard and new: some specific areas of interest include the long-term effects of treatment (or no treatment), the progression of the disease over time, and the overall length of survival of the patient.

Conditions

Interventions

TypeNameDescription
OTHERDiagnosed with GERDRecording of patient outcomes

Timeline

Start date
2014-01-01
Primary completion
2024-09-01
Completion
2024-09-01
First posted
2015-06-24
Last updated
2025-05-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02479438. Inclusion in this directory is not an endorsement.

Gastroesophageal Reflux Disease Prospective Registry (NCT02479438) · Clinical Trials Directory